Nanolayered siRNA dressing for sustained localized knockdown.
Steven Castleberry1, Mary Wang, Paula T Hammond
1Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA.
ACS Nano
|May 16, 2013
Summary
Researchers developed an ultrathin coating for localized RNA interference (RNAi) delivery. This coating on surgical dressings effectively delivers short interfering RNA (siRNA) for over a week, offering a promising local therapeutic approach.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Drug Delivery Systems
Background:
- The efficacy of RNA interference (RNAi) in therapeutics is contingent upon effective delivery technologies.
- While systemic delivery of RNAi faces challenges, localized delivery presents a more attainable strategy for various medical applications.
- Localized delivery is crucial for treating localized diseases, managing implants, tissue engineering, and regenerative medicine.
Purpose of the Study:
- To develop an innovative coating for localized and sustained delivery of short interfering RNA (siRNA).
- To evaluate the efficacy of this coating when applied to a common surgical dressing.
- To demonstrate the potential of this technology for local RNAi therapeutics.
Main Methods:
- Fabrication of an ultrathin, electrostatically assembled coating designed for siRNA encapsulation.
- Application of the siRNA-loaded coating onto a commercially available woven nylon surgical dressing.
- In vitro assessment of protein expression knockdown in multiple cell types over an extended period.
Main Results:
- The coating demonstrated sustained release and effective delivery of siRNA, leading to significant protein expression knockdown for over one week in vitro.
- The coating was successfully applied to a medically relevant device (surgical dressing).
- Effective siRNA delivery was achieved without the need for externally delivered transfection agents.
Conclusions:
- The developed ultrathin coating enables localized and sustained delivery of siRNA from a standard surgical dressing.
- This technology bypasses the need for external transfection agents, simplifying local RNAi administration.
- The findings highlight a promising new strategy for localized RNAi therapeutics in diverse medical fields.
Related Concept Videos
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:23RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...